Sign in | Register
Services
Solutions
About Us
Resources
Contact Us

Webinar - Design. Build. Scale: AAV Discovery to Process Development

aav-discovery-to-process

Adeno-associated viruses (AAVs) are widely used in gene therapy for its safety and ability to support long-term gene expression. Join us to gain integrated insights across AAV development—from vector discovery and plasmid design to process development.

chengluo
Cheng Luo
Director of Pharmacology Dept., ProBio
Luffy-Chen
Luffy Chen
Head of Plasmid PD and Production Dept., ProBio
xiyangwang
Xiyang Wang
Sr. Researcher, Viral Vector PD Dept. ProBio
Time
Topic
14:00-14:45
One-stop AAV Drug Discovery Solution, from DNA to PCC
Cheng Luo, Director of Pharmacology Dept., ProBio
From plasmid design to AAV packaging and in vitro/in vivo assays
GOI validation: assessing transduction efficiency, bioactivity, and safety
Preclinical candidate (PCC) screening
14:45-15:30
AAV Plasmid Production: Key Challenges and Control Strategies
Luffy Chen, Head of Plasmid PD and Production Dept., ProBio
Applications of antibody fragments in LNP-based targeted delivery
Platform purification strategies and key risk considerations
Development case studies
15:30-16:15
AAV Overview and Solutions in Cell and Gene Therapy
Xiyang Wang, Sr. Researcher, Viral Vector PD Dept., ProBio
Overview of AAV and applications in CGT
Challenges in AAV vector process development and production
Innovative solutions with the ProBio process platform and case study